HR Execs on the Move

Concord Regional Visiting Nurse Association

www.crvna.org

 
Concord Regional Visiting Nurse Association is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Concord, NH. To find more information about Concord Regional Visiting Nurse Association, please visit www.crvna.org
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.crvna.org
  • PO BOX 1797
    Concord, NH USA 03302-1797
  • Phone: 603.224.4093

Executives

Name Title Contact Details
Geraldine Holmes
Chief Financial Officer Profile

Similar Companies

Cordant Health Solutions

Based in Denver, Cordant Health Solutions™ provides innovative tools for monitoring and managing behavioral health, chronic pain and criminal justice cases. Our unique programs include pharmacy, clinical laboratory and analytic tools that provide actionable information to protect prescribers, improve outcomes and contain costs. As a leader in rigorous quality and compliance standards, Cordant is committed to developing groundbreaking solutions for payers, clinicians and organizations involved in the substance use disorder, criminal justice and pain management markets. Cordant offers unique risk assessment, monitoring and management tools through its integrated network of laboratories and high-touch pharmacies specializing in the management and dispensing of controlled substances and behavioral health medications. Cordant`s testing protocols and digital case-management tools help clients become more efficient and effective in assessing and managing risk, monitoring patient adherence and improving patient outcomes.

Glenn Long and Associates

Glenn Long & Associates, Inc. is a Hillsborough, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

First Med Inc

First Med Inc is a Accomac, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.

PDC Facilities

PDC Facilities Incorporated is a Hartland, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.